Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cooper

Showing results (1331-1340 of 1,657) with videos related to

Pageof 166
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zincChia-Yu Huang, Tara M Stauffer, Corey L Strickland, et al.
Synapse (New York, N.Y.)|February 17, 2009
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallyprideRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
European Journal of Heart Failure|June 27, 2018
Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registryLauren B Cooper, Jonathan Yap, Wan Ting Tay, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2000
Increased baseline occupancy of D2 receptors by dopamine in schizophreniaA Abi-Dargham, J Rodenhiser, D Printz, et al.
Bioorganic & Medicinal Chemistry|February 27, 2019
3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channelHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's diseaseChristopher J Helal, Mark A Sanner, Christopher B Cooper, et al.
Journal of the American College of Surgeons|May 27, 2014
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancerAmanda B Cooper, Holly M Holmes, Jude K A des Bordes, et al.
Peptides|April 28, 2010
Exploration of structure-activity relationships at the two C-terminal residues of potent 11mer Glucagon-Like Peptide-1 receptor agonist peptides via parallel synthesisTasir S Haque, Rogelio L Martinez, Ving G Lee, et al.
Archives of General Psychiatry|January 7, 2003
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depressionMaria A Oquendo, Giovanni P A Placidi, Kevin M Malone, et al.
Bioorganic & Medicinal Chemistry|February 28, 2018
Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocyclesHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Pageof 166

Showing results (1331-1340 of 1,657) with videos related to

Sort By:
Pageof 166
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zincChia-Yu Huang, Tara M Stauffer, Corey L Strickland, et al.
Synapse (New York, N.Y.)|February 17, 2009
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallyprideRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
European Journal of Heart Failure|June 27, 2018
Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registryLauren B Cooper, Jonathan Yap, Wan Ting Tay, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2000
Increased baseline occupancy of D2 receptors by dopamine in schizophreniaA Abi-Dargham, J Rodenhiser, D Printz, et al.
Bioorganic & Medicinal Chemistry|February 27, 2019
3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channelHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's diseaseChristopher J Helal, Mark A Sanner, Christopher B Cooper, et al.
Journal of the American College of Surgeons|May 27, 2014
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancerAmanda B Cooper, Holly M Holmes, Jude K A des Bordes, et al.
Peptides|April 28, 2010
Exploration of structure-activity relationships at the two C-terminal residues of potent 11mer Glucagon-Like Peptide-1 receptor agonist peptides via parallel synthesisTasir S Haque, Rogelio L Martinez, Ving G Lee, et al.
Archives of General Psychiatry|January 7, 2003
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depressionMaria A Oquendo, Giovanni P A Placidi, Kevin M Malone, et al.
Bioorganic & Medicinal Chemistry|February 28, 2018
Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocyclesHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Pageof 166